Some analysis for round 3 of #RheumJC

Overall (full 24hrs including both sessions) there were 63 total participants

• 20 people had participated in one of the two previous journal clubs
• 43 people were brand new
• 22 different countries were represented

Compared to last month, there were 17 more total participants

The total number of rheumatologists increased (34 in round 3, 25 in round 2)

• Additionally, this session saw a lot of cross-specialty interest with 3 nephrologists, 3 gastroenterologists, 3 internists, and 2 pediatricians also participating

For the full 24 hours, there were 569 total tweets – 390 unique tweets and 179 RTs

• Compared to round 1 – very similar: 506 total tweets – 410 unique tweets and 96 RTs
• Compared to round 2 – also very similar: 518 total tweets – 387 unique tweets and 117 RTs

In the 22 hours of asynchronous participation time (not including the 2 live sessions), the volume of tweets was relatively low (150 tweets – 26.4% of the total) and tended to be mostly RTs (63%)

The 2 live sessions accounted for 73.6% of the total tweet volume for the 24hrs

Almost 80% of the tweets during the live sessions were unique and only 20% of the tweets were RTs

Only 32 unique individuals participated in the two live sessions

Session 1 (3pm EST)

• 22 participants (5 Europe, 14 Americas, 3 Middle East)
• 6 fewer Europeans participated compared to round 2 session 1
• 3 people participated again in session 2 (9pm EST) including our guest author @RheumNow
• There were 208 total tweets – 159 unique tweets and 49 RTs

Session 2 (9pm EST)

• 13 participants (12 Americas, 1 Philippines)
• There were 211 total tweets – 175 unique tweets and 36 RTs

Symplur metrics from session 1

Symplur metrics from session 2

The next session of #RheumJC will be on Thursday, April 2nd, and we’re pleased to announce we’ll be discussing the special article from Arthritis Care & Research: Proceedings From the American College of Rheumatology Reproductive Health Summit: The Management of Fertility, Pregnancy, and Lactation in Women With Autoimmune and Systemic Inflammatory Diseases by Kavanaugh, A. and Cush, J. et al.

The session will again be run with two one-hour “live chats” at 8pm GMT (3pm EST) and 2am GMT (9pm EST).

We’re happy to announce that Wiley publishing (@Wiley_Health) has again agreed to make the article available open-access until April 10th using this link: http://onlinelibrary.wiley.com/enhanced/doi/10.1002/acr.22516/?campaign=wlytk–42083.4393981481.

We’re also pleased that author Dr. John Cush (@RheumNow) has agreed to join the sessions to answer questions (because of clinic duties, likely more available during the second session of the day).

Dr. John Cush is a rheumatologist at the Baylor University Medical Center and is Director of Clinical Rheumatology for Baylor Research Institute. He is highly highly active on social media, and his twitter account is a must-follow for anyone that works in the field of rheumatology.

If you are new to using Twitter, take a look at our Intro to Twitter page.

If you are participating in a Twitter journal club chat for the first time, please read our Getting Started Guide to get some tips on how to make the most of this session and not get too bogged down. Some additional pointers:

1. Please remember to try to stay on topic whenever possible
2. Be polite and courteous
3. Do not violate HIPAA

As always, we welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@gmail.com.

A huge thank you goes out to Lois Wingerson at @RheumatologyNet for putting together this excellent slideshow summary of our 2nd #RheumJC:

Rheumatology Network:

Rheumatology Journal Club #2: Rituximab for AAV Relapse.

Some analysis for round 2 of #RheumJC

Overall (combined sessions and time between and after) there were 46 total participants

• 20 people had participated in last month’s journal club (round 1)
• 26 people were new
• 17 different countries were represented

Compared to last month, there were 10 fewer total participants

• The total number of rheumatologists stayed the same (26 in round 1, 25 in round 2)
• 8 rheumatologists participated in both rounds 1 and 2
• 17 new rheumatologists participated in rounds 2
• Most of the attrition was from nephrology ( #NephJC occurring at same time as session 2, and “other” unidentifiable participants)

For the full 24 hours, there were 518 total tweets – 387 unique tweets and 117 RTs

• Compared to round 1 – very similar: 506 total tweets – 410 unique tweets and 96 RTs

Of the 46 participants, the top 10 tweeters accounted for 75% of the total tweets

Session 1 (3pm EST)

• 23 participants (11 Europe, 12 Americas)
• 6 people participated again in session 2 (9pm EST)
• There were 188 total tweets – 160 unique tweets and 22 RTs
• Eli (@emilosla), our invited author, squeezed of 44 unique tweets!

Session 2 (9pm EST)

• 17 participants (14 Americas, 1 India, 1 Australia, 1 unknown)
• There were 240 total tweets – 189 unique tweets and 51 RTs

Of the 6 people who participated in both of the live one hour sessions, which included both moderators, they were pretty enthusiastic tweeters accounting for 43% of the total tweets for session 1 and 75% of the tweets from session 2

The 6 people were:

• @anakinramd
• @elanaoberstein
• @hswapnil
• @psufka
• @hausmannmd (as himself for session 1 and as @rheumjc for session 2)
• @rheumpearls (as himself for session 2 and as @rheumjc for session 1)

Symplur metrics from session 1:

Symplur metrics from session 2:

After a successful launch of RheumJC last month, we are pleased to announce our second International Twitter-based Rheumatology Journal Club which will occur on Tuesday, March 3rd. Like before, there will be two one-hour “live chats”, the first being at 8pm GMT (3pm EST) and the second later that evening at 2am GMT (9pm EST). We hope these sessions will accommodate a global audience, but in case you cannot join during these times, the session will last for a full 24 hours in an asynchronous format so that anyone who wants to participate can. The hashtag for the journal club will again be #rheumjc. We will conclude at 8pm GMT on March 4th with a summary of the entire session. The two one-hour live chats will be moderated by members of the RheumJC development team.

The article chosen for our this journal club is titled “Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis” by Miloslavsky, et al, published in the November 2014 edition of Arthritis & Rheumatology, Volume 66, Issue 11, pages 3151–3159.

The Wiley publishing group has graciously agreed to make the article available open-access beginning now and lasting through March 6th. Click here to access the article: http://onlinelibrary.wiley.com/enhanced/doi/10.1002/art.38788/?campaign=wlytk–42053.1663773148

We are also extremely pleased to announce that the principal author of this manuscript, Dr. Eli Miloslavsky (@emilosla), will participate in the 8pm GMT (3pm EST) live session to answer any questions you may have about the article. Dr. Miloslavsky is a rheumatologist at Massachusetts General Hospital, an Instructor of Medicine at Harvard Medical School and the co-founder of the Vasculitis and Glomerulonephritis Center.

If you are participating for the first time, please read the section called getting started to get some tips on how to make the most of this session and not get too bogged down. Some additional pointers:

1. Please remember to try to stay on topic whenever possible
2. Be polite and courteous
3. Do not violate HIPAA

As always, we welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@gmail.com.

The good folks at Symplur were kind enough to make a network centrality graph for all #RheumJC tweet activity through the end of the first journal club. Thank you!

Also available for download is a PDF version of the graph that allows you to zoom in and see finer details.

Be sure to check out the #RheumJC page on Symplur as well for ongoing statistics updated in real time.

(I’m sure I missed some good Tweets in the Storify, but wow… there were a lot of Tweets to go through.)

Update 02/05/2015: download the full transcript of these sessions: Session 1 – Session 2

Thanks for the amazing turnout on the first #RheumJC!

Here are some of our initial metrics from Symplur:

We are very excited to announce that the inaugural session for the International Twitter-based Rheumatology Journal Club will start on Thursday, January 29th. There will be two one-hour “live chats”, the first being at 8pm GMT (3pm EST) and the second later that evening at 2am GMT (9pm EST). We hope these sessions will accommodate a global audience, but in case you cannot join during these times, the session will last for a full 24 hours in an asynchronous format so that anyone who wants to participate can. The hashtag for the journal club will be #rheumjc. We will conclude at 8pm GMT on January 30th with a summary of the entire session. The two one-hour live chats will be moderated by members of the RheumJC development team.

The article chosen for our first journal club is titled “Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up“ by Mok, et al. and is published online by the Annals of the Rheumatic Diseases.

The BMJ publishing group has graciously agreed to make the article available open-access beginning now and lasting until the session ends: [CLICK HERE for access to open access article].

Since this is our first go around at this, there are bound to be some bumps along the way. Please read the part of this website called “getting started” to get some tips on how to make the most of this session and not get too bogged down. Some additional pointers:

1. Please remember to try to stay on topic whenever possible
2. Be polite and courteous
3. Do not violate HIPAA

Here is a starting point which can help as you prepare for participation in the discussion. The Critical Appraisal Skills Program (CASP) International Network is a non-profit organization for people promoting skills in finding, critically appraising and acting on the results of research papers. Authored by the Public Health Resource Unit, NHS, England , the CASP initiative has published several checklists for the critical appraisal of research articles: http://www.caspinternational.org/?o=1012.

During the discussion we hope to cover many of these points.

In the future, we welcome suggestions for papers for discussion. The plan is to host about one journal club a month. Please send your suggestions by Direct Message on Twitter to @RheumJC. If you are having difficulty getting hold of the paper nominated for discussion, please contact us and we will do what we can to be of assistance. Our goal is to have all papers be made at least temporarily open access for the week leading up to the journal club session.